Loss of daptomycin susceptibility in clinical Staphylococcus epidermidis infection coincided with variants in WalK

Daptomycin (DAP) is key in treating multidrug-resistant Staphylococcus infections. Diminished susceptibility to DAP is emerging among Staphylococcus epidermidis strains although mechanisms for non-susceptibility (NS) remain poorly understood. We report a case of persistent S. epidermidis bacteremia...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Evol Med Public Health
Main Authors: Brazeau, Nicholas F, Levinson, Kara J, Schranz, Asher, Moser, Kara A, Hollis, Ian, Iyer, Prashanth, Chien, Christopher, Bowen, Amanda, van Duin, David, Lachiewicz, Anne, Andermann, Tessa, Jones, Melissa, Miller, Melissa, Juliano, Jonathan J, Bartelt, Luther A
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Case Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7658547/
https://ncbi.nlm.nih.gov/pubmed/33214904
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/emph/eoaa031
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados